Pegaspargase Medication Information

Discover comprehensive details about Pegaspargase, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it.

The updated prescription information covers potential side effects, precautions, warnings, and storage recommendations.

Additionally, explore the Pegaspargase brands available in India and internationally, along with pricing information. For personalized advice, consult your healthcare provider.

Generic Name : Pegaspargase

Pronunciation : peg-AS-par-jase

ICD Code : Y43.6 Therapeutic Classification : Enzymes

Brand Names or Trade Names of Pegaspargase

International :

Oncaspar

Why is Pegaspargase Prescribed? (Indications)

This medication is an antineoplastic agent, prescribed for acute lymphoblastic leukemia (ALL). It stops or slows the growth of cancer cells.

When should Pegaspargase not be taken? (Contraindications)

Contraindicated in patients with serious blood clots, bleeding disorder, chickenpox, shingles, or inflammation of the pancreas, and hypersensitivity.

What is the dosage of Pegaspargase?

IM/IV- The recommended dose is 2,500 IU/m².

How should Pegaspargase be taken?

It comes as a solution for injection to be administered by a healthcare provider into the vein or muscle.

What are the warnings and precautions for Pegaspargase?

• Caution should be exercised in patients with history of liver problems, bone marrow problems, sugar, infection, undergoing radiation therapy, any allergy, who are taking other medications, during pregnancy and breastfeeding.

• It may raise blood sugar level; monitor sugar level regularly while taking this medication.

• It may reduce platelet counts; avoid injury or bruising.

What are the side effects of Pegaspargase?

Most Common - Allergic reactions (including anaphylaxis), increased sugar, blood clotting disorder, increase in liver enzyme, inflammation of pancreas, and stroke.